About Us

SyntheticMR AB (publ) develops and markets innovative imaging solutions that enhance neuroimaging workflow efficiency and diagnostic precision. SyntheticMR’s SyMRI® solution measures brain absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single fast scan. Combinostics, a SyntheticMR company, offers the AI-powered cNeuro® suite of products that help clinicians make a difference in the lives of patients with neurological disorders. Our products are, among other things, CE-marked and FDA-approved, and we are listed on Spotlight Stock Market Exchange in Stockholm. SyntheticMR is headquartered in Linköping, Sweden, with an additional office in Tampere, Finland.